NIHR Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (DeNPRU-QM)

What is the NIHR Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (DeNPRU-QM)?

We develop and conduct research covering a disease’s journey from prevention through to the end of life. Our work informs government policy to ultimately improve the lives of those affected now and in the future. We work together with those with lived experiences of all types of dementia and neurodegenerative diseases, their family carers and charities who share their expertise with leading researchers and clinicians in health and social care.

Scope

We cover all dementias and work across neurodegenerative conditions. This includes Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, Multiple sclerosis (MS), Parkinson’s disease, Huntington’s and Motor neurone disease (MND)

Projects

We have an agreed a programme of work that DeNPRU-QM will deliver during its first three years. Here you can read a summary of each project. 

Responsive work

As well as our agreed programme of work, part of our time is to provide rapid responses to the Department of Health and Social Care (DHSC) and arms-length bodies such as such as NHS England or the Care Quality Commission (CQC).

Lived experience

A key strength of DeNPRU-QM is the integration of people with lived experience lived experience of dementia and neurodegenerative conditions into our work.

Would you like to be kept up to date on DeNPRU-QM’s work?

Please sign up to receive our regular newsletter

Our academic partners

Our organisational partners

This Policy Research Unit in Dementia and Neurodegeneration – Queen Mary University of London is funded by the National Institute for Health and Care Research (NIHR), reference NIHR206120. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care (DHSC).

You can contact DeNPRU-QM by selecting contact us.